DEXCOM (UK) LIMITED

Date	Description
01/04/251 April 2025	Statement of capital following an allotment of shares on 2025-03-14 View Document
05/03/255 March 2025	Statement of capital following an allotment of shares on 2025-02-28 View Document
09/01/259 January 2025	Full accounts made up to 2023-12-31 View Document
19/12/2419 December 2024	Statement of capital following an allotment of shares on 2024-11-22 View Document
13/05/2413 May 2024	Full accounts made up to 2022-12-31 View Document
29/08/2329 August 2023	Confirmation statement made on 2023-08-10 with updates View Document
18/08/2318 August 2023	Statement of capital following an allotment of shares on 2023-07-17 View Document
16/06/2316 June 2023	Statement of capital following an allotment of shares on 2023-05-18 View Document

22/03/2322 March 2023	Registered office address changed from Highlands House Basingstoke Road Spencers Wood Reading RG7 1NT England to Suite 4, 7th Floor 50 Broadway London SW1H 0DB on 2023-03-22 View Document
14/02/2314 February 2023	Appointment of Mr Michael Jon Brown as a director on 2023-02-02 View Document
14/02/2314 February 2023	Termination of appointment of Erik Bjorkman as a director on 2023-02-02 View Document
14/02/2314 February 2023	Appointment of Mr Iskandar Moussa as a director on 2023-02-02 View Document
15/12/2215 December 2022	Full accounts made up to 2021-12-31 View Document
28/02/2228 February 2022	Termination of appointment of Patrick Michael Murphy as a director on 2022-02-17 View Document
21/12/2121 December 2021	Full accounts made up to 2020-12-31 View Document
11/08/1511 August 2015	CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION View Document